These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11135688)

  • 1. [Changes of genomic density polymorphism and quantitative expression of complement receptor type 1 in patients with liver diseases].
    Wang H; Qian B; Niu F; Jiang A
    Zhonghua Gan Zang Bing Za Zhi; 2000 Dec; 8(6):335-7. PubMed ID: 11135688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes of ECR1 genomic density polymorphism, quantitative expression and the activity of ECR1 natural adhesion in patients with chronic hepatitis].
    Mao YL; Wang HB; Sun ZQ; Cui EB; Ma HB; Ju LC; Jiang P
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun; 17(2):146-8. PubMed ID: 12869997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of complement receptor 1 (CR1, CD35, C3b/C4b receptor) density polymorphism with glomerulonephritis in Indian subjects.
    Katyal M; Tiwari SC; Kumar A; Dinda AK; Arora V; Kumar R; Das N
    Mol Immunol; 2004 Apr; 40(18):1325-32. PubMed ID: 15072851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association between genetic polymorphism of erythrocyte CR1 and the susceptibility of idiopathic pulmonary fibrosis].
    Yuan YD; Zhao MX; Yu J
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Nov; 34(11):841-5. PubMed ID: 22333472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of complement receptor type 1 expression on red blood cells in negative phenotypes of the Knops blood group system, according to CR1 gene allotype polymorphisms.
    Pham BN; Kisserli A; Donvito B; Duret V; Reveil B; Tabary T; Le Pennec PY; Peyrard T; Rouger P; Cohen JH
    Transfusion; 2010 Jul; 50(7):1435-43. PubMed ID: 20210926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The changes and significance of red cell nature-immune-adhesion function in liver diseases at different stages].
    Wang HB; Zhang JW; Guo JX; Liu ZH
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(6):455-8. PubMed ID: 12887755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low erythrocyte complement receptor type 1 (CR1, CD35) expression in preeclamptic gestations.
    Feinberg BB; Jack RM; Mok SC; Anderson DJ
    Am J Reprod Immunol; 2005 Dec; 54(6):352-7. PubMed ID: 16305660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced erythrocyte CR1 levels in patients with pulmonary tuberculosis is an acquired phenomenon.
    Senbagavalli P; Geetha ST; Karunakaran K; Banu Rekha VV; Venkatesan P; Ramanathan VD
    Clin Immunol; 2008 Jul; 128(1):109-15. PubMed ID: 18434253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic determination of CR1 CD35 density polymorphism on erythrocytes of patients with gallbladder carcinoma.
    Jiao XY; Lü MD; Huang JF; Liang LJ; Shi JS
    World J Gastroenterol; 2004 Dec; 10(23):3480-4. PubMed ID: 15526369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of CR1 Knops polymorphism in the pathophysiology of malaria: Indian scenario.
    Gandhi M; Singh A; Dev V; Adak T; Dashd AP; Joshi H
    J Vector Borne Dis; 2009 Dec; 46(4):288-94. PubMed ID: 19959855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [RBC-CR1 genotype polymorphism and RBC immune function in childhood ITP].
    Guo S; Zhou L; Wang H
    Zhonghua Xue Ye Xue Za Zhi; 1998 Mar; 19(3):143-5. PubMed ID: 11243146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired but reversible loss of erythrocyte complement receptor 1 (CR1, CD35) and its longitudinal alteration in patients with severe acute respiratory syndrome.
    Wang FS; Chu FL; Jin L; Li YG; Zhang Z; Xu D; Shi M; Wu H; Moulds JM
    Clin Exp Immunol; 2005 Jan; 139(1):112-9. PubMed ID: 15606620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A functional single-nucleotide polymorphism in the CR1 promoter region contributes to protection against cerebral malaria.
    Teeranaipong P; Ohashi J; Patarapotikul J; Kimura R; Nuchnoi P; Hananantachai H; Naka I; Putaporntip C; Jongwutiwes S; Tokunaga K
    J Infect Dis; 2008 Dec; 198(12):1880-91. PubMed ID: 18954261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rate of loss of CR1 from ageing erythrocytes in vivo in normal subjects and SLE patients: no correlation with structural or numerical polymorphisms.
    Moldenhauer F; Botto M; Walport MJ
    Clin Exp Immunol; 1988 Apr; 72(1):74-8. PubMed ID: 2899464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CR1 density polymorphism and expression on erythrocytes of patients with systemic lupus erythematosus.
    Kiss E; Csipö I; Cohen JH; Reveil B; Kávai M; Szegedi G
    Autoimmunity; 1996; 25(1):53-8. PubMed ID: 9161700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
    Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
    J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative polymorphism of complement receptor type 1 (CR1) in patients undergoing haemodialysis.
    Tamano M; Ohi H; Sudo S; Tomino Y
    Nephrol Dial Transplant; 2004 Jun; 19(6):1467-73. PubMed ID: 15069174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CR1 levels and gene polymorphisms exhibit differential association with falciparum malaria in regions of varying disease endemicity.
    Sinha S; Jha GN; Anand P; Qidwai T; Pati SS; Mohanty S; Mishra SK; Tyagi PK; Sharma SK; Venkatesh V; Habib S
    Hum Immunol; 2009 Apr; 70(4):244-50. PubMed ID: 19480840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement receptor 1 single nucleotide polymorphisms in Czech and Dutch patients with sarcoidosis.
    Mrazek F; Kvezereli M; Garr E; Kubistova Z; Kriegova E; Fillerova R; Arakelyan A; Ruven HJ; Drabek J; van den Bosch JM; Kolek V; Welsh KI; Grutters JC; du Bois RM; Petrek M
    Tissue Antigens; 2008 Jan; 71(1):77-80. PubMed ID: 17999656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of complement receptor type I (CR1, CD35) on erythrocytes in patients with hemoplasma infection.
    Congbin Y; Aibin L; Congli Y; Juan X; Lanjun B; Weiping Z; Zhibiao Y; Xiuguo H
    Microbiol Immunol; 2010 Aug; 54(8):460-5. PubMed ID: 20646210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.